Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 2/2006

01-02-2006 | Article

Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins

Authors: Y. Jamshidi, H. Snieder, X. Wang, T. D. Spector, N. D. Carter, S. D. O’Dell

Published in: Diabetologia | Issue 2/2006

Login to get access

Abstract

Aims/hypothesis

Inhibition of signal transduction by suppressor of cytokine signalling-3 (SOCS-3) potentially influences resistance to insulin and leptin. The aim of this study was to test the association between three single-nucleotide polymorphisms (SNPs) representative of common linkage disequilibrium clusters in SOCS3 (rs4969169, rs12953258 and rs8064821) and obesity measures, insulin sensitivity measures and serum lipids in the general population.

Methods

The three SNPs, which had rare allele frequencies >0.06, were genotyped in 2,777 female twins of European extraction (mean age 47.4±12.5 years) from the St Thomas’ UK Adult Twin Registry (Twins UK).

Results

Minor allele frequencies were as follows: rs4969169=0.067, rs12953258=0.097 and rs8064821=0.101. Individual SOCS3 SNPs were not associated with general or central obesity, or with two indices of insulin sensitivity (homeostasis model assessment and insulin sensitivity measure).

Conclusions/interpretation

The results do not indicate that any of the three SNPs studied are associated with obesity, insulin measures or lipid measures.
Appendix
Available only for authorised users
Literature
1.
Krebs DL, Hilton DJ (2001) SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378–387PubMedCrossRef
2.
Munzberg H, Myers MG (2005) Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8:566–570PubMedCrossRef
3.
Pirola L, Johnston AM, Van Obberghen E (2004) Modulation of insulin action. Diabetologia 47:170–184PubMedCrossRef
4.
Gylvin T, Nolsoe R, Hansen T et al (2004) Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity. Diabetologia 47:1273–1277PubMedCrossRef
5.
6.
Andrew T, Hart DJ, Snieder H, de Lange M, Spector TD, MacGregor AJ. (2001) Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res 4:464–477PubMedCrossRef
7.
Middelberg RP, Spector TD, Swaminathan R, Snieder H (2002) Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol 22:1142–1147PubMedCrossRef
8.
de Lange M, Snieder H, Ariens RA, Andrew T, Grant PJ, Spector TD (2003) The relation between insulin resistance and hemostasis: pleiotropic genes and common environment. Twin Res 6:152–161PubMedCrossRef
9.
Trégouët D-A, Ducimetère P, Tiret, L (1997) Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations. Am J Hum Genet 61:189–199PubMedCrossRef
10.
Avignon A, Boegner C, Mariano-Goulart D, Colette C, Monnier L (1999) Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes Relat Metab Disord 23:512–517PubMedCrossRef
11.
Hanley AJ, Williams K, Gonzalez C, D’Agostino RB, Jr, Wagenknecht LE, Stern MP, Haffner SM (2003) Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52:463–469PubMedCrossRef
12.
Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79–91PubMedCrossRef
13.
Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169PubMedCrossRef
14.
Dong Y, Zhu H, Wang X, Dalageorgou C, Carter N, Spector TD, Snieder H (2004) Obesity reveals an association between blood pressure and the G-protein beta3-subunit gene: a study of female dizygotic twins. Pharmacogenetics 14:419–427PubMedCrossRef
15.
Christensen K, Vaupel J, Holm NV, Yashin AI (1995) Twin mortality after age six: fetal origin hypothesis versus twin method. BMJ 310:432–436PubMed
16.
Sham PC, Cherny SS, Purcell S, Hewitt JK (2000) Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data. Am J Hum Genet 66:1616–1630PubMedCrossRef
17.
Ueki K, Kondo T, Tseng YH, Kahn CR (2004) Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci USA 101:10422–10427PubMedCrossRef
Metadata
Title
Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins
Authors
Y. Jamshidi
H. Snieder
X. Wang
T. D. Spector
N. D. Carter
S. D. O’Dell
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-0093-3

Other articles of this Issue 2/2006

Diabetologia 2/2006 Go to the issue

Article

Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents

Article

Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover

Article

Clusterin induces differentiation of pancreatic duct cells into insulin-secreting cells

Article

Changes in hepatic glycogen cycling during a glucose load in healthy humans

Short Communication

Paradoxical rise in serum adiponectin concentration in the face of acid-induced insulin resistance 13-cis-retinoic

Short Communication

Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits